Opioid Policies

collage

Much like the rest of the United States, residents of the District of Columbia are struggling with substance use disorder (SUD) rate increases and high rates of opioid-related deaths. Unfortunately, these are multi-faceted issues that require year-long initiatives and systematic programs to address the myriad causes of addiction.

MSDC stands as a partner to the District government and private entities to help arrest the rates of opioid and substance abuse in the District. Through our advocacy for better prescribing practices, education on addiction, and even helping our own community through our Physician Health Program, MSDC is working to make DC a leader in reducing SUD, OUD, and addiction.

On a related note, MSDC is passionate about helping patients make prescriptions and medication more affordable. Whether expanding access to biosimilars or advocating for more affordable co-pays, MSDC wants to help our patients afford the medications they need.

MSDC Statement and Testimony on Opioid and Prescription Issues

25th Council information coming soon

 

Prior Auth Bill Takes Big Step Towards Becoming Law

Oct 5, 2023, 14:31 PM by MSDC Staff
The Council voted to pass the bill - see what's next for the bill to become law.

 

On Tuesday, the DC Council added to the consent agenda and voted on B25-124, the Prior Authorization Reform Amendment Act.

B25-124 is MSDC's highest priority and would enact reasonable limits on prior authorization for the first time ever in the District. Today moves the bill one step closer to reality.

Currently the District is one of only nine states without any prior authorization restrictions in law. This bill would, among other things, prevent prior auths for cost alone, set time limits for prior auth considerations, prohibit prior auth for emergency care and medication assisted treatment, and require insurers to publish prior auth guidance publicly. See our bill breakdown here.

By adding the bill to the consent agenda, the Council only needs to vote twice on the bill instead of three times. That means the bill could be passed by the Council as early as November and sent to the Mayor. One potential holdup is the bill may require an additional fiscal note from the Department of Behavioral Health.

For more information about the bill and how to be engaged with the process, visit msdc.org/priorauth.

Sample of Legislation MSDC Tracked on Opioid and Prescription Policy

 

Access to Biosimilars Amendment Act (B23-430)

What does it do? The bill authorizes licensed pahrmacists to dispense interchangeable biological products and requires notifications to physicians when such interchangeables are dispensed.

MSDC position: MSDC has a position of priority support on this legislation, identifying its passage as one of its highest legislative priorities.

Current status: SUCCESS. The bill was passed by the Council and signed by the Mayor.

Opioid Labeling Amendment Act (B23-535)

What does it do? The bill requires prescription opioid medications to include a statement that the drug is an opioid and opioids may cause dependence, addiction, or overdoes.

MSDC position: MSDC supports the legislation.

Current status: The bill had a hearing before the Committee on Health on July 29, 2020. MSDC leader Dr. Sam Kareff testified for the Medical Society. It passed the Council on November 10 and was signed by the Mayor December 7.

Pre-exposure Prophylaxis Insurance Discrimination Amendment Act (B23-36)

What does it do? The bill prohibits insurance companies from factoring the use of PreP in decisions related to disability, life, or long-term care policies.

MSDC position: MSDC supports this legislation

Current status: The bill was introduced on January 8, 2019 and assigned to the Committee on Business and Economic Development.